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BACKGROUND: The majority of testicular germ cell cancers develop through a pre-invasive carcinoma in situ (CIS) stage. The CIS cell is
a neoplastic counterpart of foetal germ cells. During their development, foetal germ cells undergo extensive and essential epigenetic
modifications, but little is known about epigenetic patterns in CIS cells.
METHODS: Immunohistochemistry was used to investigate epigenetic patterns in CIS, germ cell tumours, normal adult and foetal
testicular tissue.
RESULTS: CIS cells show low levels of DNA methylation and repressive histone modifications H3K9me2 and H3K27me3, but high
levels of H3K9 acetylation, H3K4 methylation and H2A.Z, which all are associated with an activated and accessible chromatin
structure. Collectively this renders a permissive chromatin structure and in accordance high levels of RNA polymerase II activity and
proliferation (Ki-67 and mitotic index) is observed in CIS cells. Epigenetic patterns similar to that of CIS cells were observed in human
gonocytes present within sex cords in foetal testes but correspond to migrating primordial germ cell in mice. Development of overt
tumours involves epigenetic repression of the chromatin.
CONCLUSION: CIS cells have a permissive and foetal-like chromatin structure, which is associated with a high transcriptional and
proliferative activity, likely empowering neoplastic transformation. Developmental epigenetic cues in foetal germ cells are substantially
different between humans and mice.
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Testicular cancer is the most common cancer in young men and
the incidence is increasing (Huyghe et al, 2003). Genetic
predisposition is indicated by familial cases and ethnic differences
in incidence rates but the increasing trend and major geographic
differences in incidence are consistent with environmental
influence. Increased use of endocrine disruptors has been
suggested to be one of the environmental factors responsible for
the increasing incidence of testicular cancer, which is regarded as
one of the outcomes of the testicular dysgenesis syndrome, a group
of reproductive disorders linked together by developmental origins
(Skakkebaek et al, 2001).
The vast majorities of testicular tumours are derived from germ
cells and are traditionally divided into a morphologically homo-
geneous group of seminomas and a very heterogeneous group of
non-seminomas. Even though seminomas and non-seminomas
histologically are very different, they both originate from the same
precursor called carcinoma in situ (CIS), intratubular germ cell
neoplasia or testicular intraepithelial neoplasia. Thus, CIS has a
central role in pathogenesis of testicular cancer.
Evidence from morphological (Nielsen et al, 1974; Albrechtsen
et al, 1982; Skakkebaek et al, 1987), epidemiological (Hemminki
and Li, 2002; Hemminki et al, 2002) immunohistochemical
(Rajpert-De Meyts et al, 2003; Honecker et al, 2004; Pauls et al,
2006), and gene expression profiling studies (Almstrup et al, 2004;
Sonne et al, 2009) indicate that the CIS cell is derived from a
gonocyte or primordial germ cell (PGC). We have earlier shown
that CIS cells are indistinguishable from gonocytes in terms
of gene expression profiles (Sonne et al, 2009) but the exact
developmental time point and the mechanisms of malignant
transformation remain unknown. It is possible that a slight delay
of gonadal differentiation, under-stimulation of the developing
testis or physical misplacement of PGC during migration or
colonisation of the gonad might be triggering factors. This will
imply that immature germ cells would later become neoplastic due
to their undifferentiated nature in the changed microenvironment
of the adult testis.
The PGCs and gonocytes are known to undergo extensive
epigenetic reprogramming. Seki et al (2007) observed that
migrating murine PGCs progressively erase H3K9me2 and subse-
quently establish H3K27me3 concurrently with erasure of genome-
wide DNA methylation. Both histone marks are repressive and in
the transition between erasure of H3K9me2 and establishment of
H3K27me3 PGCs most probably display a transient period with
possible hyper-transcription. Hyper-transcription seems however
to be prevented as PGCs were shown to enter G2 arrest and repress
RNA polymerase II-dependent transcription in this transition
period (Seki et al, 2007). Hajkova et al (2008) showed that mice
PGCs upon gonadal colonisation (E11.5) lose most of their linker
histone H1, H3K9ac, H3K9me3, H3K27me2 and H4/H2A R3me2.
Very little is known about the epigenetic status of CIS cells,
probably because it has not been possible to cultivate CIS cells.
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have arginine 3 of histone H2A and H4 dimethylated (H4/H2A
R3me2), which are thought to repress – among others – the HOX
genes, involved in somatic differentiation programs (Ohinata et al,
2005). Most seminomas also have high levels of H4/H2A R3me2,
whereas low levels are observed in non-seminomas (Eckert et al,
2008). It is also known that the genome of CIS cells contains very
little DNA methylation (Netto et al, 2008), in contrast to highly
methylated non-seminomas, whereas seminomas display variable
but mainly low levels of DNA methylation (Smiraglia et al, 2002;
Netto et al, 2008). This is in accordance with our findings of high
expression of the DNA methylation enzymes DNA methyl
transferase 3A and DNA methyl transferase 3L in the undiffer-
entiated non-seminoma component, embryonal carcinoma (EC),
when compared with seminoma and CIS (Almstrup et al, 2005).
As developmental epigenetic cues seem a prerequisite for proper
germ cell development in mice, we, in this study, addressed
the question whether early human neoplastic germ cells – the CIS
cells – that seem developmentally arrested, indeed could have an
epigenetic status similar to immature germ cells. We also
hypothesised that epigenetic modifications may be associated with
differences in transcriptional activity between normal and
malignant germ cells. To answer that, we systematically investi-
gated the pattern of DNA methylation and histone modifications,
which are known to be differentially set during embryonic
development of the germ line, in CIS cells and derived cancers
and compared them to the epigenetic patterns of the same
modifications in normal human germ cells in the adult testis and
in foetal gonocytes. We also assessed the transcriptional activity
and proliferation index in the CIS cells.
MATERIALS AND METHODS
Tissues
The regional Committee for Medical Research Ethics in Denmark
approved the use of human tissues stored in the tissue archives of
Copenhagen University Hospital. The tissues were obtained after
orchidectomy for testicular cancer (adult testis and testicular
tumours) from spontaneous abortions/miscarriages (foetal tissues)
and from control biopsies to monitor for relapses of acute
leukaemia (pre-pubertal testis samples). Tissue samples were fixed
overnight at 41C in buffered formalin or 4% paraformaldehyde.
Histological diagnosis was established by experienced pathologists
and confirmed by immunohistochemical staining for tumour
markers (as described below).
Immunohistochemical evaluation of DNA methylation
and histone modifications
Immunohistochemistry was performed as previously described
(Rajpert-De Meyts et al, 2003). A standard indirect peroxidase
method was used and development was done primarily with
3-amino-9-ethylcarbazole (yielding a red colour). For double staining,
colour development with 5-bromo-4-chloro-3-indolyl phosphate and
nitro blue tetrazolium was in addition applied (yielding a deep blue
colour) as previously described (Jørgensen et al, 2009).
The following antibodies were used at indicated dilutions and
buffers for microwave treatment: anti-5-methylcytosine, 1:400,
(TEG buffer) TRIS 1.21 g/l, EGTA 0.19 g/l, pH 9.0 (5-meC;
Calbiochem, Darmstadt, Germany, NA81), rabbit anti-human
placental alkaline phosphatase, 1:300, TEG buffer (placental-like
alkaline phosphate; Thermo Fisher Scientific, Waltham, MA, USA,
RM-9115-S0), anti-dimethyl-histone H3 (Lys9) 1:250, TEG buffer
(H3K9me2; Millipore, Billerica, MA, USA, 07–441), anti-trimethyl-
Histone H3 (Lys27), 1:500, citrate buffer (H3K27me3; Millipore,
07–449); anti-histone H3 (mono methyl Lys4), 1:6000, TEG buffer
(H3K4me1; Abcam, Cambridge, MA, USA, ab8895), anti-histone
H3 (diþtri methyl Lys4), 1:2000, TEG buffer (H3K4me2/3; Abcam,
ab6000), anti-EZH2, 1:2500, urea buffer (Millipore, 07–689),
anti-UTX, 1:50, urea buffer (Abcam, ab36938), anti-JMJD3, 1:75,
citrate buffer (Millipore, 07–1533), anti-histone H3 (acetyl Lys9),
1:10000, citrate buffer (H3K9ac; Abcam, ab10812), anti-histone
H2A.Z 1:3000, citrate buffer (Abcam, ab4174), anti-RNA polymer-
ase II (N-20), 1:500, citrate buffer (Santa Cruz Biotechn-
ology, Santa Cruz, CA, USA, sc-899), anti-RNA polymerase
II Ser-2 phosphorylated, 1:200, TEG buffer (H5; Covance,
Princeton, NJ, USA, MMS129R), anti-OCT4 (C-10), 1:250, urea
buffer (Santa Cruz Biotechnology, sc5279). For negative controls,
serial sections were processed with the primary antibody replaced
by the dilution buffer alone. None of the control slides showed
any staining (data not shown). Stained slides were scanned
on a NanoZoomer (Hamamatsu Photonics, Herrsching am
Ammersee, Germany) and analysed using the software NDPview
(Hamamatsu Photonics). For each antibody at least three different
samples of the same histology were investigated. Intensity of the
staining, in cells from the histology in question, was evaluated and
scored from negative (neg) to strong positive (þþþ) as outline
in Table 1.
Proliferation index
A total of 13 tissue samples containing CIS (no overt tumours) and
four normal adult testes (patients with obstructive forms of
infertility) were included. The proliferation rate was assessed by
two methods: the mitotic index and the Ki-67-labelling index and
proliferation rates of CIS cells were compared with those of normal
spermatogonia. Biopsies were fixed in formalin or Stieve’s fixative
and stained with haematoxylin and eosin or by immunohisto-
chemistry for placental alkaline phosphatase (mouse anti-human
placental alkaline phosphatase; placental-like alkaline phosphate;
Dako, Glostrup, Denmark, M7191) to identify CIS cells, and Ki-67
(Dako, M7189) to mark proliferating cells.
Statistical analysis was conducted by Mann–Whitney U-test
to compare the median of two unmatched groups and Kruskal–
Wallis test to compare averages of more than two samples.
RESULTS
DNA methylation levels in CIS cells
We first verified results from earlier work on the level of DNA
methylation as measured by cytosine methylation (Smiraglia et al,
2002; Netto et al, 2008). The classical cytoplasmic CIS marker,
placental-like alkaline phosphate, was used simultaneously with
staining for 5-methyl-cytosine and indeed verified low levels of
DNA methylation in CIS cells (Figure 1B). We also confirmed that
non-seminomas have high levels of DNA methylation, whereas
seminomas show variable but predominantly low DNA methyla-
tion levels (data not shown).
Histone modifications in CIS cells
Immunohistochemical staining for the repressive chromatin
modifications H3K9me2 and H3K27me3 revealed low levels of
these modifications in CIS cells, whereas Sertoli cells in CIS-
containing tubules showed high levels of both modifications
(Figure 1C and D).
Activating modifications H3K4me1 and H3K4me2/3 were
observed abundant in CIS cells, whereas a weak staining was
observed in Sertoli cells (Figure 1E and F). Furthermore, H3K9ac
as well as H2A.Z were strongly positive in CIS cells but present at a
much lower level in Sertoli cells (Figure 1G and H).
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Seminomas showed high levels of H3K9me2, H3K27me3,
H3K4me1 and H2A.Z, whereas low levels of H3K4me2/3 and
H3K9ac were observed (Supplementary Figure S1). Some variation
was observed for the H3K9me2 mark between seminoma samples
(from a faint staining to strongly positive).
The undifferentiated component of non-seminomas, EC, showed
no H3K27me3 and H3K9me2 staining but moderate levels of
H3K4me2/3 methylation. A weak staining was observed for
H3K4me1, H3K9ac and H2A.Z in EC (Supplementary Figure S1).
Histone modifications in normal adult testis
In normal testicular tissue H3K9me2 showed a very specific signal
in a subset of spermatogonia, probably type A, and in round and
elongating spermatids, whereas Sertoli cells was only faintly
stained (Supplementary Figure S1), in contrast to the strongly
stained Sertoli cells in CIS tubules (Figure 1C).
H3K27me3 by contrast was present in a broader set of germ cells
with a low level in most spermatogonia and higher expression in
round to elongating spermatids. Sertoli cells show high levels of
H3K27me3 in both normal and CIS-containing tubules (Supple-
mentary Figure S1 and Figure 1D).
H3K4me1 was observed in high levels in a subset of
spermatogonia, probably type B but was also weakly present in
other types of spermatogonia and Sertoli cells. Expression was
again observed in late round spermatids but not in elongated
spermatids. However, H3K4me2/3 was observed in a broad range
of germ cells including elongating spermatids and in Sertoli cells
(Supplementary Figure S1).
Figure 1 Epigenetic patterns in carcinoma in situ (CIS) testis visualised by immunohistochemistry. (A) A typical tubule with CIS cells marked by one of
the classical markers, OCT4 (POU5F1) (de Jong et al, 2005; Rajpert-De Meyts et al, 2004). Note that CIS cells are bigger than unstained spermatogonia (visible in
the tubule on the right) and have large irregular nuclei with coarse chromatin clumps. (B) Double staining for 5-methyl-cytosine (reddish brown) and the classical
CIS marker placental-like alkaline phosphate (PLAP, dark blue). (C) H3K9me2. (D) Double staining for H3K27me3 (deep blue) and PLAP (reddish brown). (E)
H3K4me1, (F) H3K4me2/3, (G) H3K9ac and (H) H2A.Z. Arrows denote CIS cells and arrowheads Sertoli cells. Bar represent 50 microns.
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in spermatocytes but was absent from late spermatids. A low level
was observed in Sertoli cells. Expression of H2A.Z was similar to
the observed levels of H3K9ac, except that H2A.Z was highly
expressed in round spermatids (Supplementary Figure S1).
Histone modifications in human foetal and pre-pubertal
germ cells
Samples of foetal gonad tissue ranging from gestation week 17 to
41 were investigated to explore the level of histone modifications
in human foetal germ cells. Foetal germ cells around GW 21–24
showed no DNA methylation and absence of repressive H3K9me2,
H3K27me3 modifications (Figure 2B–D). In contrast, H3K9ac and
H2A.Z were very abundant in foetal germ cells (Figure 2G and H).
Surprisingly, H3K4me1 was observed in the cytoplasm of foetal
germ cells and H3K4me2/3 was observed in high levels in only a
subset of the foetal germ cells (Figure 2E and F). It was roughly
estimated that 20% of the foetal germ cells around GW 21 were
marked with H3K4me2/3 with slight variations in the amount of
positive foetal germ cells observed at earlier and later time points.
However, no definitive trend could be identified.
The level of the investigated histone modifications did not differ
significantly between foetal and adult Sertoli cells except for
H3K9me2, which was found in high levels in Sertoli cells
surrounding CIS and in foetal germ cells but not in normal Sertoli
cells of any age (Figures 1C, 2C and supplementary Figure S1).
All results are outlined in Table 1.
Regulation of the H3K27me3 mark in CIS cells
Demethylation of di- and tri-methylated histone H3 at K27 can be
carried out by the Jumonji proteins UTX and JMJD3 (Agger et al,
2007), whereas methylation of H3K27 can be carried out by
Figure 2 Histone modifications in human foetal gonads. Fetal testis tissues at GW 21–24 marked by immunohistochemical staining for (A) OCT4
(POU5F1) to visualise gonocytes, (B) 5-methylcytosine (5-meC), (C) H3K9me2, (D) H3K27me3, (E) H3K4me1, (F) H3K4me2/3, (G) H3K9ac and (H)
H2A.Z. Arrows indicate foetal germ cells. Bar represents 50 microns.
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component of the Polycomb repressive complex 2 (Cao et al, 2002;
Czermin et al, 2002).
We observed that UTX and JMJD3 were not expressed in CIS
cells (Supplementary Figure S2B and C) but surprisingly, EZH2
was highly expressed in the cytoplasm of CIS cells (Supplementary
Figure S2A). JMJD3 was weakly expressed in Sertoli cells, whereas
only a faint EZH2 staining was observed in the cytoplasm of Sertoli
cells. In overt tumours, faint staining of both proteins was
observed, except for EZH2 expression in EC, which was totally
absent (data not shown).
Re-evaluation of earlier genome-wide studies of gene expression
in CIS cells (Almstrup et al, 2004; Skotheim et al, 2005; Sonne et al,
2009) did not indicate that any of the Polycomb genes or other
transcripts encoding for proteins known to be involved in
modifying histones were differentially expressed in CIS cells when
compared with normal testicular tissue or gonocytes.
Transcriptional activity and proliferation of CIS cells
Methylation of histone H3K9 demarcates heterochromatin,
whereas H3K4 methylation demarcates euchromatin (Fischle
et al, 2003; Li et al, 2008) and collectively the above histone
modifications observed in CIS cells could indicate an ‘open’ and
permissive chromatin structure in CIS cells. We thus investigated
the levels of RNA polymerase II and its Ser2-phosphorylated
variant as measured by the H5 antibody. Ser2 phosphorylation is
tightly associated with transcriptional elongation (Phatnani and
Greenleaf, 2006) and is a marker of the global transcriptional
activity. Both RNA polymerase II and its Ser2-phosporylated
variant were present in CIS cells in high levels (Figure 3A and B)
indicating that transcription is highly active in CIS cells.
The RNA polymerase II was also highly expressed in a subset of
spermatocytes and spermatogonia, in seminomas, but was,
surprisingly, lower expressed in EC than CIS. High expression of
RNA polymerase II, however, did not always correlate with a
strong H5 antibody staining. In seminomas, the H5 level was low
and expression of RNA polymerase II was high, whereas both RNA
polymerase II itself and its active Ser2 form were observed in
moderate levels in EC (data not shown).
These data suggested that CIS cells are highly transcriptionally
active, which could reflect a high proliferation rate. Assessment of the
proliferation rate of CIS cells was thus investigated by counting the
mitotic index and the Ki-67-labelling index on 13 tissue sections
containing CIS. Comparison of both mitotic index and Ki-67-labelling
index of CIS cells and spermatogonia indeed indicated that CIS cells
are highly proliferative. A statistically significant difference (P¼0.001)
was observed between the mitotic index and Ki-67-labelling index
of normal spermatogonia and those of the CIS cells (Table 2). No
significant differences in the proliferation ratios were observed
between the CIS cells adjacent to seminomas compared with CIS
cells adjacent to non-seminomas (data not shown).
DISCUSSION
In this study, we performed a detailed analysis of epigenetic status
of germ cell neoplasia and show that the precursor for the majority
Table 1 Summary of epigenetic patterns in normal and neoplastic testicular tissues
Putative
function CIS Gonocytes
a SEM
NonSEM
(EC) Normal adult testis
5-methyl-
cytosine
Chromatin
repression
neg neg neg/++ +++ Sp.gonia: all, Sp.cytes: all, Sp.tids: all
Sertoli: ++ Sertoli: ++ Sertoli: ++
H3K9me2 Chromatin
repression
neg neg +/+++ neg Sp.gonia: A +++, Sp.cytes: neg, Sp.tids: round and elongated ++/neg
Sertoli: +++ Sertoli: ++ Sertoli: neg/+
H3K27me3 Chromatin
repression
neg/+ neg/+ +++ neg Sp.gonia: neg/+, Sp.cytes: neg, Sp.tids: round to elongating +++/+
Sertoli: +++ Sertoli: ++ Sertoli: +++
H3K4me1 Chromatin
activation
+++ neg/+ (cytoplasma) ++/+++ neg/+ Sp.gonia: B, Sp.cytes: neg, Sp.tids: late round ++
Sertoli: + Sertoli: neg Sertoli: +
H3K4me2/3 Chromatin
activation
++/+++  /++ neg/+ +/++ Sp.gonia: ++/+++, Sp.cytes: +/+++, Sp.tids: round +/++
Sertoli: + Sertoli:  /+ Sertoli: +/++
H3K9ac Chromatin
activation
+++ +++ neg/+ neg/+ Sp.gonia: +++/+, Sp.cytes: ++/neg, Sp.tids: neg
Sertoli: neg/+ Sertoli: neg/+ Sertoli: +
H2A.Z Chromatin
activation
+++ +++ ++/+++ neg/+ Sp.gonia: +/+++, Sp.cytes: ++, Sp.tids: round +++
Sertoli: neg/+ Sertoli: neg/++ Sertoli: +
EZH2 H3K27 tri-
methylation
+++ (cytoplasma) Neg neg/+ neg Sp.gonia: neg (+ cytoplasma), Sp.cytes: neg, Sp.tids: neg
Sertoli: neg Sertoli: neg Sertoli: neg
UTX H3K27me3
demethylation
neg Neg neg/+ neg/+ Sp.gonia: neg, Sp.cytes: neg/+, Sp.tids: neg
Sertoli: + Sertoli: neg Sertoli: neg
JMJD3 H3K27me3
demethylation
neg neg/+ neg/+ neg/+ Sp.gonia: neg/+, Sp.cytes: neg/++, Sp.tids: neg/+
Sertoli: neg/+ Sertoli: neg Sertoli: neg/+ (cytoplasma)
Abbreviations: EC; embryonal carcinoma; EZH2, Enhancer of Zeste homologue 2; neg, negative; NonSEM, non-seminoma; SEM; seminoma; Sp.tid, spermatid; Sp.cytes,
spermatocytes; Sp.gonia, spermatogonia. +, faint staining; ++, apparent; +++, strong positive.
aGestational week 20–40.
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repressive chromatin modifications (H3K9me2 and H3K27me3)
concurrently with low DNA methylation and a range of activating
chromatin modifications (H3K4me, H3K9ac, and H2A. Z). We also
show that RNA polymerase II seems to be very active in CIS cells,
and that this fits with a high proliferation rate of CIS cells.
On the basis of a high similarity between gene expression
profiles of CIS cells and gonocytes we have earlier suggested that
the CIS cell is a transformed gonocyte (Sonne et al, 2009). The
present data further substantiate that hypothesis as the epigenetic
profiles of gonocytes and CIS are highly similar but markedly
differ from those of adult germ cells. The only exception was the
level of H3K4me1 and H3K4me2/3 that were both abundantly
present in the CIS nucleus but had only a limited presence in foetal
germ cells. H3K4me2/3 was observed only in a subset of foetal
germ cells, most likely gonocytes, which at the gestational age in
the samples available for the study constitute only a very small
minority of foetal germ cells. Identification of histone variants in
the cytoplasm often indicates that they are bound for degradation
by chaperones but the importance of the apparent discrepancy
between foetal germ cells and CIS is currently unknown.
Methylation of histone H3 at Lys4 is, however, known to be
tightly associated with methylation of DNA. During embryonic
development RNA polymerase II binds to CpG islands and directs
H3K4 methylation by recruitment of H3K4 methyltransferases
(Guenther et al, 2007). Such CpG regions are consequently
methylated at Lys4 of histone H3, whereas the rest of the genome
contains unmethylated H3K4. In fact, DNA methyl transferase 3L
is known to interact directly with histone H3 when unmethylated
at Lys4 and facilitate de novo methylation. Consequently, DNA
methylation may be prevented at such CpG islands primed by RNA
polymerase II due to methylation of H3K4. This is in line with the
correlation between the high levels of H3K4 methylation and
the low DNA methylation levels observed in CIS cells. In addition,
the high RNA polymerase II levels could be a consequence of the
correlation between RNA polymerase occupancy, H3K4 methyla-
tion and low DNA methylation. Similarly, it is known that H2A.Z
protects genes from DNA methylation (Zilberman et al, 2008), so
the high H2A.Z expression in CIS cells is consistent with their low
DNA methylation. Loci containing H2A.Z have been observed
predominantly at sites occupied by RNA polymerase II along with
enhancer regions (Barski et al, 2007) and again this seems to fit
with the observed high levels of elongating RNA polymerase II in
CIS cells. However, we do not know whether the DNA methylation
in CIS cells may be hydroxylated and thus unrecognised by the
currently used antibodies (Tahiliani et al, 2009; Huang et al, 2010).
Low DNA methylation in the gene body and out of a CpG context
has recently been suggested to be of great importance in
embryonic stem cells (Ramsahoye et al, 2000; Lister et al, 2009).
In mice, during PGC migration a progressive erasure of
H3K9me2 and establishment of H3K27me3 occurs concurrently
with genome-wide erasure of DNA methylation (Seki et al, 2007).
In addition, as the PGC colonise the gonad in mice, a range of
other epigenetic events occurs, which includes erasure of both
H2A.Z and H3K9ac (Hajkova et al, 2008). One of the important
findings of our study is that the regulation of these chromatin
marks is substantially different in humans. Migration of human
PGCs takes place during GW 4–6 and after GW 6 germ cells are
observed in the gonadal anlage and begin to be surrounded by
immature Sertoli cells. From that point of time, the term gonocyte
is used to describe the germ cells in the male gonad (Fujimoto
et al, 1977). At GW 21–24, human gonocytes are definitively
post-migrational germ cells but show low levels of H3K27me3 and
high levels of H3K9ac and H2A.Z, which is comparable with
migrating mouse PGC. In addition, human foetal germ cells at GW
16–24, show absence, or very low levels, of H3K9me3 (Bartkova
et al, 2010). High levels of H4/H2A R3me2s have also been
reported in human GW 19 gonocytes (Eckert et al, 2008), matching
the epigenetic profile of migrating PGCs in mice (Seki et al, 2007;
Hajkova et al, 2008). There is a possibility that all of these marks
are transiently reverted in mouse gonocytes at a later foetal age,
however, it is not likely, given that the subset of murine germ cells,
recognised later as stem spermatogonia, do retain some features of
PGC, including high expression of pluripotency genes.
Presumably there is a tight connection between the epigenetic
and DNA repair machinery (Hajkova et al, 2008) and previous
studies has demonstrated that CIS cells and foetal germ cells use
different machinery of cell cycle and DNA repair than that
operating in post-pubertal germ cells (for review, see Bartkova
et al, 2007). This is clearly linked to the post-pubertal switch to
meiotic division, which requires double breaks of DNA and their
Figure 3 RNA polymerase II activity in CIS cells. Immunohistochemical
detection of RNA polymerase II (A) and its Ser2-phosphorylated variant as
measured by the H5 antibody (B). Arrows denotes CIS cells and
arrowheads Sertoli cells. Bar represent 50 microns.
Table 2 Proliferation index
MI (median) Ki-67 (mean)
CIS 1.58% (n¼13) 17.42% (n¼4)
Spermatogonia 0.25% (n¼4) 6.75% (n¼4)
CIS vs spermatogonia P¼0.001 Po0.001
Abbreviations: CIS, carcinoma in situ; MI, mitotic index.
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The similarities between the epigenetic profile of CIS and foetal
germ cells are in concert with these data.
Taken together our results clearly indicate that the CIS genome
seems to have a open and foetal-like chromatin structure, which
potentially could lead to chromosomal instability and subse-
quently a malignant phenotype, as observed in some somatic
cancers, for example, colorectal cancer (Rodriguez et al, 2006).
High proliferation rates of CIS cells could be a consequence of the
open chromatin in CIS cells but stimulation by gonadotropins and
androgens, which normally induce proliferation and maturation of
germ cells in the post-pubertal testis, may also have a role. It is
currently unknown whether the epigenetic profile observed in CIS
remains the same or dynamically changes during malignant
progression.
Enhancer of Zeste homologue 2 is one of the key enzymes
involved in creating the H3K27me3 mark, and we observed it to be
highly expressed in the cytoplasm of CIS cells. This enzyme is
known to be amplified in a large range of cancers (Bracken et al,
2003) and in prostate cancer it is involved in promoting
proliferation and invasiveness (Bryant et al, 2007). In benign
prostate epithelial cells, EZH2 is expressed at low levels in the
cytoplasm but becomes overexpressed in prostate cancer cells, in
which its putative function is regulation of actin polymerisation
(Su et al, 2005; Bryant et al, 2008). However, it is not known whether
EZH2 is involved in actin regulation in CIS cells or whether the
cytoplasmic location is a result of a defective translocation to the
nucleus, but EZH2 is most probably not engaged in its ‘normal’
function as part of polycomb or swi/snf complexes as none of the
genes encoding co-enzymes were observed overexpressed in CIS.
In contrast to CIS, overt germ cell tumours derived from CIS
cells seem to have acquired variable epigenetic modifications.
Seminomas show high levels of selected repressive modifications,
exemplified by H3K9me2 and H3K27me3. Non-seminomas,
however, show high methylation levels (Smiraglia et al, 2002;
Netto et al, 2008), but the embryonal carcinoma, which is the most
undifferentiated component of non-seminomas, nevertheless
retains a very open and foetal-like histone profile. We observed
some heterogeneity, but many more samples need to be investigated
to deduce whether, for example, there are discrete subsets
of seminomas with different modification patterns. Heterogeneity
of DNA methylation was indeed observed in seminomas in which
6 out of 33 samples were positive (Netto et al, 2008).
Concepts of epigenetic plasticity in cells, which upon niche
disturbances stochastically select for epigenetic heterogeneity and
consequently, facilitate the ability of cells to acquire abnormal
characteristics, have been put forward (Ushijima and Asada, 2009;
Feinberg and Irizarry, 2010). These data are in line with this
concept and the current views on the pathogenesis of germ cell
tumours, which suggest that developmental disturbances of the
somatic niche could result in improper maturation of foetal germ
cells (Skakkebaek et al, 2001). We can add to this hypothesis that
developmental delay of germ cell maturation results in preserva-
tion of the permissive foetal epigenetic profile, which on hormone
stimulation during puberty leads to an aberrant induction of
transcription and proliferation, ultimately leading to germ cell
cancer later in life.
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